Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy

被引:69
|
作者
Gradoni, L
Scalone, A
Gramiccia, M
Troiani, M
机构
[1] Laboratory of Parasitology, Istituto Superiore di Sanità, Rome
[2] Laboratorio di Parassitologia, Istituto Superiore di Sanità, 299-00161 Rome, Viale Regina Elena
关键词
surveillance; leishmaniasis; HIV-1; AIDS;
D O I
10.1097/00002030-199606001-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To actively detect leishmaniasis in HIV-1-infected individuals in Italy, to describe the epidemiological features of the disease in these patients, and to compare them with epidemiological features of leishmaniasis in HIV-negative patients. Design: Retrospective and prospective surveillance study. Patients: Italian patients with HIV-1 infection and leishmaniasis diagnosed between 1985 and 1994. Results: We recorded 116 leishmaniasis cases (115 visceral leishmaniasis), of which 94 (81%) were diagnosed over the last 4 years. Seventy-eight patients (67%) fulfilled the 1993 Centers for Disease Control and Prevention AIDS criteria. Leishmaniasis was passively reported in only 18% of cases. Leishmania incidence estimated among approximately 2700 AIDS patients living leishmaniasis endemic areas averaged 1.6%, with a maximum of 4.9% in Sicily. These rates were up to 500-fold higher than among HIV-negative individuals living in the same areas, and were similar to those of ubiquitous opportunistic agents indicative of AIDS condition. Data from two major endemic regions indicated that overlap of HIV-1 and Leishmania infections has focal characteristics. The occurrence of small case clusters would suggest occasional modes of Leishmania transmission different from the insect vector. The isoenzyme characterization of 38 Leishmania stocks showed a zymodeme spectrum qualitatively and quantitatively different from that of the parasitic agent of visceral leishmaniasis in HIV-negative adults. Conclusions: Active surveillance provided reliable evaluation on the occurrence of HIV-Leishmania coinfections in Italy, although it was limited to hospital-based cases in this study due to general under-reporting of cases. Biological and epidemiological spectrum of the disease suggests that visceral leishmaniasis should be included among AIDS-defining pathologies.
引用
收藏
页码:785 / 791
页数:7
相关论文
共 50 条
  • [41] ANTIBODIES TO SOLUBLE CD4 IN HIV-1-INFECTED INDIVIDUALS
    THIRIART, C
    GOUDSMIT, J
    SCHELLEKENS, P
    BARIN, F
    ZAGURY, D
    DEWILDE, M
    BRUCK, C
    AIDS, 1988, 2 (05) : 345 - 351
  • [42] Plasma and Salivary IgA Subclasses and IgM in HIV-1-Infected Individuals
    Xueling Wu
    Susan Jackson
    Journal of Clinical Immunology, 2002, 22 : 106 - 115
  • [43] Factors associated with admissions in HIV-1-infected individuals in the era of multiple HIV interventions
    Craig, J.
    Bergin, C.
    O'Connell, S.
    Carr, P.
    HIV MEDICINE, 2017, 18 : 50 - 50
  • [44] ANTI-HIV ACTIVITY OF THE COMBINATION OF DIDANOSINE AND HYDROXYUREA IN HIV-1-INFECTED INDIVIDUALS
    BIRON, F
    LUCHT, F
    PEYRAMOND, D
    FRESARD, A
    VALLET, T
    NUGIER, F
    GRANGE, J
    MALLEY, S
    HAMEDISANGSARI, F
    VILA, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1995, 10 (01) : 36 - 40
  • [45] Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patient
    Clevenbergh, P
    Okome, MN
    Benoit, S
    Bendini, JC
    De Salvador, F
    Elbeze, M
    Cassuto, E
    Marty, P
    Dellamonica, P
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2002, 34 (07) : 546 - 547
  • [46] EFFECT OF PURIFIED IGGS FROM HIV-1-INFECTED AND NON INFECTED INDIVIDUALS ON IMMUNE ACTIVATION
    CHAMS, V
    BIOU, D
    CHO, YY
    MBIKA, JP
    LECOQ, H
    HESHMATI, F
    FOUCHARD, M
    BIZZINI, B
    ZAGURY, JF
    BIOMEDICINE & PHARMACOTHERAPY, 1994, 48 (5-6) : 267 - 272
  • [47] Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
    Connor, RI
    Sheridan, KE
    Ceradini, D
    Choe, S
    Landau, NR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04): : 621 - 628
  • [48] Epitope Specificities of Elite Neutralizing Sera from HIV-1-Infected Individuals
    Tomaras, G.
    Binley, J.
    Gray, E.
    Shen, X.
    Moore, P.
    Decker, J.
    Yates, N.
    Haynes, B.
    Cohen, M.
    Shaw, G.
    Montefiori, D.
    Mascola, J.
    Morris, L.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A24 - A24
  • [49] Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals
    De Maat, MMR
    Mathôt, RAA
    Veldkamp, AI
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    Van Gorp, ECM
    Carlier, H
    Beijnen, JH
    PHARMACOLOGICAL RESEARCH, 2002, 46 (03) : 295 - 300
  • [50] THE CUTANEOUS RESPONSE TO RECOMBINANT INTERLEUKIN-2 IN HIV-1-INFECTED INDIVIDUALS
    MCELRATH, MJ
    KAPLAN, G
    COHN, ZA
    CLINICAL RESEARCH, 1990, 38 (02): : A405 - A405